Protalix BioTherapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP PLX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

38,518

Value ($000)

69

Weight

0.0%

2020 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	69	0.0%	38,518	12/31/2025
2025 Q3	11/14/2025	162	0.0%	72,922	9/30/2025
2025 Q2	8/14/2025	442	0.0%	298,567	6/30/2025
2025 Q1	5/14/2025	2,198	0.0%	858,650	3/31/2025
2024 Q3	11/14/2024	72	0.0%	70,817	9/30/2024
2024 Q2	8/15/2024	185	0.0%	158,247	6/30/2024
2024 Q1	5/7/2024	96	0.0%	76,118	3/31/2024
2023 Q4	2/14/2024	184	0.0%	103,250	12/31/2023
2023 Q2	8/11/2023	32	0.0%	15,864	6/30/2023
2022 Q3	11/14/2022	231	0.0%	222,261	9/30/2022
2022 Q1	5/16/2022	13	0.0%	12,119	3/31/2022
2021 Q4	2/14/2022	68	0.0%	81,950	12/31/2021
2021 Q3	11/15/2021	334	0.0%	251,171	9/30/2021
2021 Q2	8/11/2021	541	0.0%	283,145	6/30/2021
2021 Q1	5/17/2021	909	0.0%	203,813	3/31/2021
2020 Q4	2/16/2021	202	0.0%	55,589	12/31/2020